The U.S. Food and Drug Administration (FDA) last month approved a new indication for somapacitan-beco injection 5 mg, 10 mg, or 15 mg for the treatment of children aged 2.5 years and older who have growth failure due to inadequate secretion of endogenous growth hormone. Novo Nordisk is marketing the treatment as Sogroya® The FDA approval...
Mutations of the Fragile X messenger ribonucleoprotein 1 gene (Fmr1) — a leading genetic cause of intellectual impairment and autism — contribute to premature ovarian failure (POF) due to changes in neurons that regulate reproduction in the brain and ovaries, according to a study recently published in Frontiers in Endocrinology. Researchers led by Djurdjica Coss,...
The Endocrine Society will host medical students and residents from the Chicago area at a new special event — Endocrinology Mentor Day (eMD) — at ENDO 2023. This is a pilot program designed to drive medical students’ and residents’ interest in endocrinology and connect them with leaders in the field. Participants will be matched with an...
Endocrine Society Advocates for NIH Funding, Diabetes Prevention; Conducts Diabetes Hill Day
On April 17, a group of Endocrine Society members walked the halls of Congress to meet with their elected representatives and advocate for our priorities related to funding for biomedical research and treatment and prevention of diabetes. Our asks were timely and important; we urged Congress to support an overall funding level of $51 billion...